— Know what they know.
Not Investment Advice

VSBC OTC

VitaSpring Biomedical Co. Ltd.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -98.9% 1Y: -98.9% 3Y: -99.9% 5Y: -99.9%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 46 · $2.3M mcap · 98M float · 0.0001% daily turnover

Balance Sheet Trends

Total Assets
$15K +0.0% ▲
5Y CAGR: +5.1%
Total Liabilities
$4M +0.0% ▲
5Y CAGR: +199.8%
Shareholders Equity
-$4M +0.0% ▲
Cash & Investments
$2K +0.0% ▲
5Y CAGR: +81.8%
Total Debt
$0 +0.0% ▲
Net Debt
-$2K +0.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2026
— Assets —
Cash$0$45K$107K$30K$2K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$0$45K$107K$30K$2K
Net Receivables$0$0$3M$380K$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$0$189K$3M$437K$11K
Property, Plant & Equip.$0$0$525K$305K$4K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$290K$138K$0$0
Other Non-Current Assets$0$0-$120K$24K$0
Total Non-Current Assets$0$290K$542K$329K$4K
Total Assets$0$189K$4M$766K$15K
— Liabilities —
Accounts Payable$0$0$1M$2M$3M
Short-Term Debt$0$0$0$170K$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$94K$270K$1M
Total Current Liabilities$0$93K$2M$3M$4M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$470K$93K$0
Total Liabilities$0$93K$2M$3M$4M
— Equity —
Common Stock$4K$19K$21K$21K$21K
Retained Earnings-$22K-$447K$817K-$3M-$6M
Accumulated OCI$0-$290K-$137$0$0
Total Stockholders Equity-$18K$387K$2M-$2M-$4M
Total Liabilities & Equity-$18$189K$4M$766K$15K
— Key Metrics —
Total Debt$0$0$464K$263K$0
Net Debt$0-$45K$356K$233K-$2K
Total Investments$0$290K$138K$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms